<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>323(3)</volume><submitter>Matta MK</submitter><pubmed_abstract>&lt;h4>Importance&lt;/h4>A prior pilot study demonstrated the systemic absorption of 4 sunscreen active ingredients; additional studies are needed to determine the systemic absorption of additional active ingredients and how quickly systemic exposure exceeds 0.5 ng/mL as recommended by the US Food and Drug Administration (FDA).&lt;h4>Objective&lt;/h4>To assess the systemic absorption and pharmacokinetics of the 6 active ingredients (avobenzone, oxybenzone, octocrylene, homosalate, octisalate, and octinoxate) in 4 sunscreen products under single- and maximal-use conditions.&lt;h4>Design, setting, and participants&lt;/h4>Randomized clinical trial at a clinical pharmacology unit (West Bend, Wisconsin) was conducted in 48 healthy participants. The study was conducted between January and February 2019.&lt;h4>Interv</pubmed_abstract><journal>JAMA</journal><pagination>256-267</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6990686</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Effect of Sunscreen Application on Plasma Concentration of Sunscreen Active Ingredients: A Randomized Clinical Trial.</pubmed_title><pmcid>PMC6990686</pmcid><pubmed_authors>Oh L</pubmed_authors><pubmed_authors>Bashaw E</pubmed_authors><pubmed_authors>Sanabria C</pubmed_authors><pubmed_authors>Michele T</pubmed_authors><pubmed_authors>Adah S</pubmed_authors><pubmed_authors>Zusterzeel R</pubmed_authors><pubmed_authors>Matta MK</pubmed_authors><pubmed_authors>Volpe DA</pubmed_authors><pubmed_authors>Ganley C</pubmed_authors><pubmed_authors>Patel V</pubmed_authors><pubmed_authors>Pilli NR</pubmed_authors><pubmed_authors>Kemp S</pubmed_authors><pubmed_authors>Godfrey A</pubmed_authors><pubmed_authors>Wang J</pubmed_authors><pubmed_authors>Zineh I</pubmed_authors><pubmed_authors>Florian J</pubmed_authors><pubmed_authors>Yang Y</pubmed_authors><pubmed_authors>Coelho S</pubmed_authors><pubmed_authors>Strauss DG</pubmed_authors><pubmed_authors>Furlong LA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Effect of Sunscreen Application on Plasma Concentration of Sunscreen Active Ingredients: A Randomized Clinical Trial.</name><description>&lt;h4>Importance&lt;/h4>A prior pilot study demonstrated the systemic absorption of 4 sunscreen active ingredients; additional studies are needed to determine the systemic absorption of additional active ingredients and how quickly systemic exposure exceeds 0.5 ng/mL as recommended by the US Food and Drug Administration (FDA).&lt;h4>Objective&lt;/h4>To assess the systemic absorption and pharmacokinetics of the 6 active ingredients (avobenzone, oxybenzone, octocrylene, homosalate, octisalate, and octinoxate) in 4 sunscreen products under single- and maximal-use conditions.&lt;h4>Design, setting, and participants&lt;/h4>Randomized clinical trial at a clinical pharmacology unit (West Bend, Wisconsin) was conducted in 48 healthy participants. The study was conducted between January and February 2019.&lt;h4>Interv</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Jan</publication><modification>2026-04-30T02:15:13.079Z</modification><creation>2020-07-31T09:16:31Z</creation></dates><accession>S-EPMC6990686</accession><cross_references><pubmed>31961417</pubmed><doi>10.1001/jama.2019.20747</doi></cross_references></HashMap>